Postma Robert W 4
4 · ZIOPHARM ONCOLOGY INC · Filed Sep 3, 2021
Insider Transaction Report
Form 4
Postma Robert W
Director
Transactions
- Purchase
Common Stock
2021-09-02$1.73/sh+20,508$35,479→ 1,201,870 total - Purchase
Common Stock
2021-09-02$1.73/sh+54,492$94,271→ 4,250,000 total(indirect: See footnote)
Holdings
- 3,574(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the "Units") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock.
- [F2]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.